Benefit for patient and society
Our results will not only lead to a better treatment of patients, but also to avoidance of unnecessary treatment.
The use of new targeted therapeutic modalities will lead to a significant cost increase for the Dutch health care system. However, several reports have shown that administration of targeted therapies based on genetic analysis of the patients’ tumor leads to a more rational use of these costly drugs by avoiding treatment of patients that will not benefit from these therapies. The selective use of targeted drugs by selection of those patients that benefit most will be required to make the new treatment of cancer affordable for the Dutch healthcare system.
We see this as our strongest contribution to society. In addition, we feel we also have an important task in education and communication, as detailed in the next paragraphs.
Mobile DNA-lab ‘Read the language of the tumor’
In the current high school curriculum, DNA is an important yet rather isolated topic that pupils often perceive as complex and highly abstract. In order to introduce modern DNA-research to schools and to make pupils acquainted with current genomics topics and their implications for society, the CGC has developed a mobile DNA-lab that is offered free of charge to all secondary schools (4-6 havo/vwo) in the Netherlands. The 4hr educational modules contain a 2hr practical lab taught at the schools by university students with up-to-date genomics equipment and techniques.
The pupils are given the role of DNA-researchers and are asked to compare DNA from cancer cells of a (fictive) patient with DNA of healthy cells. Based on their results, they have to advise the physician on the optimal treatment of this particular patient. The module was developed in collaboration with the Freudenthal Institute for Science Education of Utrecht University in line with the recommendations of the Committee Innovation Biology Education (‘Commissie Vernieuwing Biologie Onderwijs’) regarding the context-concept approach. Since its start in September 2005, the DNA-lab has reached over 40,000 secondary school students in het Netherlands.
Teachers can obtain additional information and register at www.dnalabs.nl
The mobile DNA-lab is further supported by information on cancer and genomics on the website www.allesoverdna.nl (in Dutch). Here teachers and pupils can find teaching materials and tests to prepare for the school exam.
28 Aug 2017
Amgen Foundation launches Amgen Biotech Experience in the Netherlands
In the next three years, the DNA Labs on the Road will collaborate with the Amgen Biotech Experience to educate Dutch high school students about biotechnology.Read more >
16 Jun 2017
CGC members awarded Spinoza Prize
We proudly congratulate our CGC members Alexander van Oudenaarden and Albert Heck for being awarded the Spinoza Prize. Albert Heck, isprofessor in the field of mass spectrometryand proteomics. Alexander van Oudenaarden is professor of quantitative biology of gene regulation and director of the Hubrecht Institute.Read more >
18 Nov 2016
Gogola wins CGC poster award
On November 18th, Ewa Gogola (NKI) was awarded with the CGC poster award 2016. Eva received the award during the KIT meeting on Genomic Instability in Cancer for her poster entitled 'Loss of PARG causes PARP inhibitor resistance in BRCA2-deficient mouse mammary tumors'.Read more >
More News >
16 & 17 Nov 2017
CGC annual meeting New Horizons in Cancer Research
On 16-17 November 2017, CGC will host its annual meeting entitled 'New Horizons in Cancer Research'. Attendance is free of charge however. Registration is closed. Location: Koninklijk Instituut voor de Tropen, Mauritskade 63 Amsterdam.Read more >
29 Sep 2017
CGC PI meeting
This year 10 new PI's joined the CGC consortium. During the meeting on September 29 they will present their work and expertise.Read more >
31 May - 02 Jun 2017
Workshop: Functional Analysis of Sequence Variants in Hereditary Breast- and Ovarian Cancer Genes
Improving Genetic Counseling and Cancer Treatment StrategiesRead more >
More Events >